The patent relates to a “Pharmaceutical composition comprising ivabradine hydrochloride polymorph IV”
Brief outline of the case
Claim 1 as granted was lacking IS over D2=WO 2013/064307. This document was the first document cited in the ESR and was qualified as X,D,Y. The same applied to AR1.